Clonal structure, extended-spectrum β-lactamases,and acquired AmpC-type cephalosporinases of Escherichia coli populations colonizing patients in rehabilitation centers in four countries

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 1, 2013, Pages 309-316

  Izdebski, R ^a   Baraniak, A ^a   Fiett, J ^a   Adler, A ^b   Kazma, M ^b   Salomon, J ^c   Lawrence, C ^d   Rossini, A ^e   Salvia, A ^e   Vidal Samso, J ^f   Fierro, J ^f   Paul, M ^g   Lerman, Y ^b   Malhotra Kumar, S ^h   Lammens, C ^h   Goossens, H ^h   Hryniewicz, W ^a   Brun Buisson, C ⁱ   Carmeli, Y ^b   Gniadkowski, M ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c INSTITUT PASTEUR   (France)

^d Groupe Hospitalier Universitaire Paris Ile de France Ouest   (France)

^e IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^f University Institute affiliated with the Autonomous University of Barcelona   (Spain)

^g LOEWENSTEIN REHABILITATION HOSPITAL   (Israel)

^h UNIVERSITY OF ANTWERP   (Belgium)

ⁱ UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; BETA LACTAMASE AMPC; BETA LACTAMASE CMY 2; BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 14; CEPHALOSPORINASE; EXTENDED SPECTRUM BETA LACTAMASE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; ENZYME STRUCTURE; ESCHERICHIA COLI; FRANCE; HUMAN; ISRAEL; ITALY; MAJOR CLINICAL STUDY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; REHABILITATION CENTER; SPAIN;

BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CLONE CELLS; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; EUROPE; HUMANS; ISRAEL; PHYLOGENY; PHYLOGEOGRAPHY;

EID: 84872023454     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01656-12     Document Type: Article

References (55)

1. Rozenberg-Arska M, Visser MR. 2004. Enterobacteriaceae, p 2189-2202. In Cohen J, Powderly WG (ed), Infectious diseases, vol 2. Mosby, St. Louis, MO.
2. Bradford PA. 2001. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951.
3. Jacoby GA. 2009. AmpC beta-lactamases. Clin. Microbiol. Rev. 22:161-182.
4. Pitout JD, Laupland KB. 2008. Extended-spectrum β-lactamase- producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8:159-166.
5. Carattoli A. 2009. Resistance plasmid families in Enterobacteriaceae. Antimicrob. Agents Chemother. 53:2227-2238.
6. Woodford N, Turton JF, Livermore DM. 2011. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol. Rev. 35:736-755.
7. Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Karch H, Reeves PR, Maiden MC, Ochman H, Achtman M. 2006. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol. Microbiol. 60:1136-1151.
8. Selander RK, Caugant DA, Whittam TS. 1987. Genetic structure and variation in natural populations of Escherichia coli, p 1625-1648. In Neidhardt FC, Ingraham JL, Low KB, Magasanik B, Schaechter M, Umbarger HE (ed), Escherichia coli and Salmonella typhimurium: cellular and molecular biology. American Society for Microbiology, Washington, DC.
9. Oteo J, Perez-Vazquez M, Campos J. 2010. Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr. Opin. Infect. Dis. 23:320-326.
10. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, Peixe L, Baquero F, Canton R, Nordmann P. 2008. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg. Infect. Dis. 14:195-200.
11. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, Ayala J, Coque TM, Kern-Zdanowicz I, Luzzaro F, Poirel L, Woodford N. 2007. CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 59:165-174.
12. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Canica MM, Park YJ, Lavigne JP, Pitout J, Johnson JR. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-281.
13. Rogers BA, Sidjabat HE, Paterson DL. 2011. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 66:1-14.
14. Rossolini GM, D'Andrea MM, Mugnaioli C. 2008. The spread of CTX-TABLE M-type extended-spectrum β-lactamases. Clin. Microbiol. Infect. 14(Suppl 1):33-41.
15. Drieux L, Brossier F, Sougakoff W, Jarlier V. 2008. Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae: review and bench guide. Clin. Microbiol. Infect. 14(Suppl 1):90-103.
16. Perez-Perez FJ, Hanson ND. 2002. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40:2153-2162.
17. Adler A, Gniadkowski M, Baraniak A, Izdebski R, Fiett J, Hryniewicz W, Malhotra-Kumar S, Goossens H, Lammens C, Lerman Y, Kazma M, Kotlovsky T, Carmeli Y. Transmission dynamics of ESBL-producing E. coli clones in rehabilitation wards at a tertiary care center. Clin. Microbiol. Infect., in press.
18. Struelens MJ, Rost F, Deplano A, Maas A, Schwam V, Serruys E, Cremer M. 1993. Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis. Am. J. Med. 95:489-498.
19. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
20. Grundmann H, Hori S, Tanner G. 2001. Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms. J. Clin. Microbiol. 39:4190-4192.
21. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
22. Bauernfeind A, Grimm H, Schweighart S. 1990. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 18:294-298.
23. Empel J, Baraniak A, Literacka E, Mrowka A, Fiett J, Sadowy E, Hryniewicz W, Gniadkowski M. 2008. Molecular survey of β-lactamases conferring resistance to newer β-lactams in Enterobacteriaceae isolates from Polish hospitals. Antimicrob. Agents Chemother. 52:2449-2454.
24. Empel J, Hrabak J, Kozinska A, Bergerova T, Urbaskova P, Kern-Zdanowicz I, Gniadkowski M. 2010. DHA-1-producing Klebsiella pneumoniae in a teaching hospital in the Czech Republic. Microb. Drug Resist. 16:291-295.
25. Literacka E, Empel J, Baraniak A, Sadowy E, Hryniewicz W, Gniadkowski M. 2004. Four variants of the Citrobacter freundii AmpC-type cephalosporinases, including novel enzymes CMY-14 and CMY-15, in a Proteus mirabilis clone widespread in Poland. Antimicrob. Agents Chemother. 48:4136-4143.
26. Woodford N, Fagan EJ, Ellington MJ. 2006. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases. J. Antimicrob. Chemother. 57:154-155.
27. Ben Sallem R, Ben Slama K, Estepa V, Jouini A, Gharsa H, Klibi N, Saenz Y, Ruiz-Larrea F, Boudabous A, Torres C. 2012. Prevalence and characterisation of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates in healthy volunteers in Tunisia. Eur. J. Clin. Microbiol. Infect. Dis. 31:1511-1516.
28. Mugnaioli C, Luzzaro F, De Luca F, Brigante G, Perilli M, Amicosante G, Stefani S, Toniolo A, Rossolini GM. 2006. CTX-M-type extended-spectrum β-lactamases in Italy: molecular epidemiology of an emerging countrywide problem. Antimicrob. Agents Chemother. 50:2700-2706.
29. Gibreel TM, Dodgson AR, Cheesbrough J, Fox AJ, Bolton FJ, Upton M. 2012. Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from northwest England. J. Antimicrob. Chemother. 67:346-356.
30. Leflon-Guibout V, Blanco J, Amaqdouf K, Mora A, Guize L, Nicolas-Chanoine MH. 2008. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J. Clin. Microbiol. 46:3900-3905.
31. Peirano G, van der Bij AK, Gregson DB, Pitout JD. 2012. Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region. J. Clin. Microbiol. 50:294-299.
32. van der Bij AK, Peirano G, Goessens WH, van der Vorm ER, van Westreenen M, Pitout JD. 2011. Clinical and molecular characteristics of extended-spectrum-β-lactamase-producing Escherichia coli causing bacteremia in the Rotterdam area, Netherlands. Antimicrob. Agents Chemother. 55:3576-3578.
33. Blanco J, Mora A, Mamani R, Lopez C, Blanco M, Dahbi G, Herrera A, Blanco JE, Alonso MP, Garcia-Garrote F, Chaves F, Orellana MA, Martinez-Martinez L, Calvo J, Prats G, Larrosa MN, Gonzalez-Lopez JJ, Lopez-Cerero L, Rodriguez-Bano J, Pascual A. 2011. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain. J. Antimicrob. Chemother. 66:2011-2021.
34. Fam N, Leflon-Guibout V, Fouad S, Aboul-Fadl L, Marcon E, Desouky D, El-Defrawy I, Abou-Aitta A, Klena J, Nicolas-Chanoine MH. 2011. CTX-M-15-producing Escherichia coli clinical isolates in Cairo (Egypt), including isolates of clonal complex ST10 and clones ST131, ST73, and ST405 in both community and hospital settings. Microb. Drug Resist. 17:67-73.
35. Johnson JR, Urban C, Weissman SJ, Jorgensen JH, Lewis JS, II, Hansen G, Edelstein PH, Robicsek A, Cleary T, Adachi J, Paterson D, Quinn J, Hanson ND, Johnston BD, Clabots C, Kuskowski MA. 2012. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob. Agents Chemother. 56:2364-2370.
36. Van der Bij AK, Peirano G, Pitondo-Silva A, Pitout JD. 2012. The presence of genes encoding for different virulence factors in clonally related Escherichia coli that produce CTX-Ms. Diagn. Microbiol. Infect. Dis. 72:297-302.
37. Dimou V, Dhanji H, Pike R, Livermore DM, Woodford N. 2012. Characterization of Enterobacteriaceae producing OXA-48-like carbapenemases in the UK. J. Antimicrob. Chemother. 67:1660-1665.
38. Mushtaq S, Irfan S, Sarma JB, Doumith M, Pike R, Pitout J, Livermore DM, Woodford N. 2011. Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases. J. Antimicrob. Chemother. 66:2002-2005.
39. Naas T, Cuzon G, Gaillot O, Courcol R, Nordmann P. 2011. When carbapenem-hydrolyzing β-lactamase KPC meets Escherichia coli ST131 in France. Antimicrob. Agents Chemother. 55:4933-4934.
40. Peirano G, Asensi MD, Pitondo-Silva A, Pitout JD. 2011. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli from Rio de Janeiro, Brazil. Clin. Microbiol. Infect. 17:1039-1043.
41. Clermont O, Dhanji H, Upton M, Gibreel T, Fox A, Boyd D, Mulvey MR, Nordmann P, Ruppe E, Sarthou JL, Frank T, Vimont S, Arlet G, Branger C, Woodford N, Denamur E. 2009. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 64:274-277.
42. Lau SH, Kaufmann ME, Livermore DM, Woodford N, Willshaw GA, Cheasty T, Stamper K, Reddy S, Cheesbrough J, Bolton FJ, Fox AJ, Upton M. 2008. UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25:H4-ST131 clone. J. Antimicrob. Chemother. 62:1241-1244.
43. Coelho A, Mora A, Mamani R, Lopez C, Gonzalez-Lopez JJ, Larrosa MN, Quintero-Zarate JN, Dahbi G, Herrera A, Blanco JE, Blanco M, Alonso MP, Prats G, Blanco J. 2011. Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain). J. Antimicrob. Chemother. 66:517-526.
44. Oteo J, Diestra K, Juan C, Bautista V, Novais A, Perez-Vazquez M, Moya B, Miro E, Coque TM, Oliver A, Canton R, Navarro F, Campos J. 2009. Extended-spectrum β-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2. Int. J. Antimicrob. Agents 34:173-176.
45. Cerquetti M, Giufre M, Garcia-Fernandez A, Accogli M, Fortini D, Luzzi I, Carattoli A. 2010. Ciprofloxacin-resistant, CTX-M-15-producing Escherichia coli ST131 clone in extraintestinal infections in Italy. Clin. Microbiol. Infect. 16:1555-1558.
46. Giufre M, Graziani C, Accogli M, Luzzi I, Busani L, Cerquetti M. 2012. Escherichia coli of human and avian origin: detection of clonal groups associated with fluoroquinolone and multidrug resistance in Italy. J. Antimicrob. Chemother. 67:860-867.
47. Cagnacci S, Gualco L, Debbia E, Schito GC, Marchese A. 2008. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J. Clin. Microbiol. 46:2605-2612.
48. Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, Zhanel GG. 2009. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob. Agents Chemother. 53:2733-2739.
49. Bert F, Johnson JR, Ouattara B, Leflon-Guibout V, Johnston B, Marcon E, Valla D, Moreau R, Nicolas-Chanoine MH. 2010. Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis. J. Clin. Microbiol. 48:2709-2714.
50. Suzuki S, Shibata N, Yamane K, Wachino J, Ito K, Arakawa Y. 2009. Change in the prevalence of extended-spectrum-β-lactamase-producing Escherichia coli in Japan by clonal spread. J. Antimicrob. Chemother. 63:72-79.
51. Vincent C, Boerlin P, Daignault D, Dozois CM, Dutil L, Galanakis C, Reid-Smith RJ, Tellier PP, Tellis PA, Ziebell K, Manges AR. 2010. Food reservoir for Escherichia coli causing urinary tract infections. Emerg. Infect. Dis. 16:88-95.
52. Johnson JR, Nicolas-Chanoine MH, DebRoy C, Castanheira M, Robicsek A, Hansen G, Weissman S, Urban C, Platell J, Trott D, Zhanel G, Clabots C, Johnston BD, Kuskowski MA. 2012. Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg. Infect. Dis. 18:598-607.
53. Vervoort J, Baraniak A, Gazin M, Lammens C, Kazma M, Grabowska A, Izdebski R, Carmeli Y, Gniadkowski M, Goossens H, Malhotra-Kumar S. 2012. Characterization of two new CTX-M-25-group extended-spectrum β-lactamase variants identified in Escherichia coli isolates from Israel. PLoS One 7:e46329. doi:10.1371/journal.pone.0046329.
54. Navon-Venezia S, Chmelnitsky I, Leavitt A, Carmeli Y. 2008. Dissemination of the CTX-M-25 family β-lactamases among Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae and identification of the novel enzyme CTX-M-41 in Proteus mirabilis in Israel. J. Antimicrob. Chemother. 62:289-295.
55. De Champs C, Sirot D, Chanal C, Bonnet R, Sirot J. 2000. A 1998 survey of extended-spectrum β-lactamases in Enterobacteriaceae in France. The French Study Group. Antimicrob. Agents Chemother. 44:3177-3179.